In diabetes, it was postulated that, through the increased serum level of sphingomyelinase phosphodiesterase acid-like 3b (SMPDL3b), ceramide accumulates in the podocytes and contributes to podocytopenia [20]. The gene discussed is SMPDL3B; the disease is diabetes mellitus.